We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
IBA-Radcal

Download Mobile App




Body's Internal Clock Controls Blood Pressure

By HospiMedica staff writers
Posted on 12 Mar 2007
The body's internal clock's control of blood pressure (BP) has implications for treating heart attacks and stroke, claims a new study.

Researchers at the University of Pennsylvania School of Medicine (Penn; Philadelphia, PA, USA) conducted a study using mice in which the function of major clock genes had been disrupted. More...
The investigators found that genes relevant to the production and breakdown of catecholamines--a class of neurotransmitters secreted by the adrenal glands that includes adrenalin, norepinephrine, and dopamine--were under the control of the clock. Using a mouse model in which both catecholamines and BP were made to surge, the researchers found that the rise in both BP and catecholamines depended on the time of the stress; the greatest response occurred at a time that would correspond to the early morning hours in humans.

Surprisingly, when the investigators deleted a core clock gene completely, they managed to abolish both the catecholamine and blood pressure response to stress, irrespective of when the stress was applied during the daily clock cycle. This effect was specific to the catecholamines, as the stress response to corticosteroids was unaltered. The study was published in the February 27, 2007, issue of the Proceedings of the [U.S.] National Academy of Sciences (PNAS).

"These results integrate for the first time the two leading explanations for the diurnal variation in blood pressure and reveal an unexpected role for a clock gene in regulating the stress response,” said senior author Garret A. FitzGerald, M.D., director of the Institute for Translational Medicine and Therapeutics at Penn. "They raise the novel possibility of modifying blood pressure and consequently the early-morning risk of heart attack and stroke by using drugs to 'reset' the molecular clock.”

The molecular clock is a complex set of genes located in a discrete brain area that tightly regulate circadian rhythms in behavior, temperature, and metabolism. Researchers now appreciate that this master clock also interacts with clocks in almost all types of tissues.


Related Links:
University of Pennsylvania School of Medicine

Gold Member
12-Channel ECG
CM1200B
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Pressure Guidewire
SavvyWire
Radiation Safety Barrier
RayShield Intensi-Barrier
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.